Dapper3 Inhibitors

Lithium Chloride inhibits GSK-3β, a kinase that phosphorylates and thereby inactivates Dapper3. By inhibiting GSK-3β, Lithium Chloride would prevent the phosphorylation-dependent inactivation of Dapper3, thereby indirectly maintaining Dapper3 in its active form.

SB-216763 is another GSK-3β inhibitor. It works similarly to Lithium Chloride by preventing the inactivation of Dapper3 through the inhibition of its phosphorylation by GSK-3β, allowing Dapper3 to remain active.

BIO is a specific GSK-3β inhibitor that would halt the phosphorylation and subsequent inactivation of Dapper3, keeping it functionally active.

XAV-939 stabilizes Axin by inhibiting tankyrase, leading to β-catenin degradation. Since Dapper3 is known to antagonize Wnt/β-catenin signaling by interacting with Dishevelled, XAV-939's stabilization of Axin and consequent attenuation of Wnt/β-catenin signaling may reduce the functional necessity for Dapper3, indirectly decreasing its activity.

IWP-2 inhibits Wnt production by blocking porcupine, a membrane-bound O-acyltransferase that is required for Wnt secretion. With reduced Wnt signaling, the antagonistic role of Dapper3 against Dishevelled in the Wnt/β-catenin pathway would be less required, leading to an indirect decrease in Dapper3 activity.

LGK-974 is a porcupine inhibitor that works similarly to IWP-2, leading to reduced Wnt ligand availability and secretion. By diminishing Wnt signaling, the demand for Dapper3's activity in the cell would be indirectly lessened as its role is to antagonize the pathway.

1-[1,1'-Biphenyl]-4-yl-2-(2,3-dihydro-9H-imidazo[1,2-a]benzimidazol-9-yl)-ethanone Hydrobromide is a small molecule inhibitor of the TCF/β-catenin complex. By inhibiting TCF/β-catenin-mediated transcription, the inhibitor removes the need for Dapper3's function as an antagonist in the Wnt/β-catenin signaling pathway, thus indirectly reducing Dapper3's activity.

JW55 inhibits the activity of PARP domain-containing protein tankyrase, leading to the stabilization of Axin and the promotion of β-catenin degradation. This reduction in β-catenin signaling indirectly decreases the need for Dapper3's antagonistic activity against Dishevelled in the Wnt/β-catenin pathway.

KY02111 promotes the degradation of β-catenin by inhibiting the Wnt/β-catenin pathway. By decreasing β-catenin levels, it would indirectly reduce the requirement for Dapper3's functional activity as a negative regulator of this pathway.

FH535 inhibits both Wnt/β-catenin and PPAR signaling pathways. By inhibiting the Wnt/β-catenin pathway, FH535 would decrease the functional necessity of Dapper3, which acts to antagonize this pathway.